<?xml version="1.0" encoding="UTF-8"?>
<ref id="b112-ir-2019-09155">
 <label>112</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Nakaya</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Fujita</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Satake</surname>
    <given-names>A</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Delayed HBV reactivation in rituximab-containing chemotherapy: how long should we continue anti-virus prophylaxis or monitoring HBV-DNA?</article-title>
  <source>Leuk Res</source>
  <year>2016</year>
  <volume>50</volume>
  <fpage>46</fpage>
  <lpage>49</lpage>
  <pub-id pub-id-type="pmid">27665181</pub-id>
 </element-citation>
</ref>
